Dr. Jeffrey R. Jay, M.D. »

Silence Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 808k 6.08
2022-09-30 $692k 69k 10.04
2022-06-30 $4.8M 401k 11.85
2022-03-31 $8.4M 444k 19.00
2021-12-31 $11M 444k 23.89

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Amylyx Pharmaceuticals (AMLX)
Zura Bio Class A Ord Shs (ZURA)
Disc Medicine (IRON)
Rapt Therapeutics Com New (RAPT)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Vor Biopharma Com New (VOR)
Dianthus Therapeutics (DNTH)
Jade Biosciences Com New (JBIO)
Kalvista Pharmaceuticals (KALV)
Contineum Therapeutics Cl A (CTNM)
Eupraxia Pharmaceuticals (EPRX)
Fulcrum Therapeutics (FULC)
Nektar Therapeutics Com New (NKTR)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Nantahala Capital Management
Vivo Capital
Nextech Invest
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
5AM Venture Management
Polygon Management
Millennium Management
SG Americas Securities
Boothbay Fund Management
UBS Group

View all funds holding Silence Therapeutics